Mega Roxicin Tablets 150 mg
Mega Roxicin Tablets 150 mg
Pharmaceutical
| Ingredients and content | Roxithromycin 150mg |
| Efficacy · effect |
○ Effective bacterial species Streptococcus, Streptococcus pneumoniae, Meningococcus, Gonorrhea, Bordetella whooping cough, catarrhal, diphtheria, clostridium Perfringens, Mycoplasma pneumoniae, Chlamydia Trachomatis, Ureaplasma Urealiticum, Legionella Pneumophila, Campylobacter pylori, Plant Campylobacter, Gardnerella Vaginalis, Influenza bacillus, Staphylococcus aureus, Cholera, Parakeet disease Chlamydia ○ Indications Respiratory infections such as laryngitis, acute bronchitis, tonsillitis, bacterial pneumonia, and mycoplasma pneumonia - Genital infections and sexually transmitted diseases excluding infections caused by gonorrhea - Otitis media, sinusitis - Folliculitis, boil , edema, angioedema, solitary, cellulitis, lymphangiitis, live hand, paronychia purulent - To prevent infection in case of contact with a patient with meningococcal meningitis - Pericronitis, periodontitis |
| Usage · Dosage |
Adults : 150 mg ( titer ) is orally administered twice a day before meals in the morning and evening as roxithromycin. In case of pneumonia, administer 300 mg ( titer ) once a day before breakfast. It may increase or decrease according to age and symptoms. |
| Period of use and storage method | 36 months from the date of manufacture , in an airtight container , stored at room temperature (1~30℃ ) |
| Packaging information |
30 tablets / bottle , 300 tablets / bottle |
